Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: Results of a randomized controlled trial

Diabetes Care

Volumn 23, Issue 12, 2000, Pages 1823-1829

  O'Hare, Paul ^a,b   Bilous, R ^b   Mitchell, T ^b   O'Callaghan, C J ^b   Viberti, G C ^b   Willoughby, R ^b   Riley, J ^b   Robinson, A M ^b   Reckless, J P ^b   Havard, F ^b   Sampson, M ^b   Lloyd, A ^b   Williams, T ^b   Vora, J ^b   Chattington, P ^b   Hampson, K ^b   Ibrahim, H ^b   Borthwick, L ^b   Viberti, G ^b   Russell, C ^b   Barnes, D ^b   Macklin, A ^b   Murphy, E ^b   Stephens, E ^b   Vincent, J ^b   Tindall, H ^b   Simpson, H ^b   Knowles, E ^b   Cunningham, B ^b   Simpson, E ^b   Bilous, M ^b   O'Halloran, D ^b   Nugent, S ^b   Hadden, D ^b   Fetherstone, M ^b   McCarton, D ^b   McGurk, C ^b   Johnston, C ^b   Burton, J ^b   Harris, C ^b   Baksi, A ^b   Bartlett, J ^b   Heaton, C ^b   Brown, K ^b   Arora, A ^b   Burke, J ^b   Najim, V ^b   Cassar, J ^b   Coppini, D ^b   Chazan, B ^b   Kennedy, R ^b   Smith, J ^b   Flynn, M ^b   Lewis, A ^b   Jeffcoate, W ^b   Peck, G ^b   Pound, N ^b   Large, D ^b   Clarke, M ^b   Llewellyn, H ^b   Ang, H ^b   Davidson, G ^b   McKenna, T ^b   Byrne, P ^b   Fiad, T ^b   Hayes, F ^b   McGra, J ^b   Peters, J ^b   Davies, M ^b   Press, M ^c   Price, D ^b   Jones, L ^b   Wareham, K ^b   Scarpello, J ^b   Hodgson, E ^b   Scott, R ^b   Chaudry, A ^b   Lord, G ^b   Parsons, D ^b   Smyth, C ^b   Tymms, D ^b   Fairhurst, M ^b   White, W ^b   Hepburn, D ^b   Beer, J ^b   Nasir, J ^b   Smith, C ^b   Lenox Smith, A ^b   Braithwaite, I ^b   Michael, A ^b   Seymour, I ^b   Laffealy, S ^b   Johnson, W ^b   Patel, S ^b   Halls, H ^b   Davall, H ^b   Schyns, C ^b   more..

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b Royal Free London ^*

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; RAMIPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE DURATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; URINARY EXCRETION;

EID: 0033646954     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.12.1823     Document Type: Article

References (32)

1. Pathogenesis, prevention and treatment of diabetic nephropathy
2. Diabetic nephropathy in type 1 insulin-dependent diabetes: An epidemiological study
3. Early detection of patients at risk of developing diabetic nephropathy: A longitudinal study of urinary albumin excretion
4. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus
5. Predicting diabetic nephropathy in insulin-dependent diabetes mellitus
6. Incipient nephropathy in type 1 (insulin-dependent) diabetes
7. Influence of proteinuria on vascular disease, blood pressure and lipoproteins in insulin-dependent diabetes mellitus
8. Effect of metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: An update of the Steno studies
9. Effect of two years of strict metabolic control in long-term insulin-dependent diabetes
10. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial
11. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy
12. Randomised placebocontrolled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
13. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies
14. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension
15. Effect of captopril on heavy proteinuria in azotemic diabetes
16. Effect of captopril on kidney function m insulin-dependent diabetic patients with nephropathy
17. Beneficial effects on angiotensin-converting enzyme inhibition on renal function in patients with diabetic nephropathy
18. Renal protective effect of enalapril in diabetic nephropathy
19. Protection of kidney function and decrease in albuminuria by captopril in insulin-dependent diabetics with nephropathy
20. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria
21. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria
22. Effect of different antihypertensive agents on normotensive microalbuminuric patients with IDDM and NIDDM
23. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria
24. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria
25. Small doses of ramipril to reduce microalbuminuria in diabetic patients with incipient nephropathy, independent of blood pressure changes
26. Comparison of reduction in microalbuminuria by enalapril and hydrochlorthiazide in normotensive patients with insulin-dependent diabetes
27. Angiotensin-converting enzyme inhibition with a low dose of enalapril in normotensive diabetics with persistent proteinuria
28. Iohexol clearance for the determination of glomerular filtration rate in clinical practice: Evidence for a new gold standard
29. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure
30. ACE inhibition during two years did not improve urinary albumin excretion in normotensive microalbuminuric IDDM patients
31. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE sub-study
32. Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion